168 related articles for article (PubMed ID: 31416420)
1. Stoichiometric gene-to-reaction associations enhance model-driven analysis performance: Metabolic response to chronic exposure to Aldrin in prostate cancer.
Marín de Mas I; Torrents L; Bedia C; Nielsen LK; Cascante M; Tauler R
BMC Genomics; 2019 Aug; 20(1):652. PubMed ID: 31416420
[TBL] [Abstract][Full Text] [Related]
2. A Multi-Level Systems Biology Analysis of Aldrin's Metabolic Effects on Prostate Cancer Cells.
Bedia C; Dalmau N; Nielsen LK; Tauler R; Marín de Mas I
Proteomes; 2023 Mar; 11(2):. PubMed ID: 37092452
[TBL] [Abstract][Full Text] [Related]
3. Phenotypic malignant changes and untargeted lipidomic analysis of long-term exposed prostate cancer cells to endocrine disruptors.
Bedia C; Dalmau N; Jaumot J; Tauler R
Environ Res; 2015 Jul; 140():18-31. PubMed ID: 25817993
[TBL] [Abstract][Full Text] [Related]
4. Preprocessing Tools Applied to Improve the Assessment of Aldrin Effects on Prostate Cancer Cells Using Raman Spectroscopy.
Olmos V; Bedia C; Tauler R; Juan A
Appl Spectrosc; 2018 Mar; 72(3):489-500. PubMed ID: 29154675
[TBL] [Abstract][Full Text] [Related]
5. GPRuler: Metabolic gene-protein-reaction rules automatic reconstruction.
Di Filippo M; Damiani C; Pescini D
PLoS Comput Biol; 2021 Nov; 17(11):e1009550. PubMed ID: 34748537
[TBL] [Abstract][Full Text] [Related]
6. Integration of Metabolomics and Transcriptomics Reveals Major Metabolic Pathways and Potential Biomarker Involved in Prostate Cancer.
Ren S; Shao Y; Zhao X; Hong CS; Wang F; Lu X; Li J; Ye G; Yan M; Zhuang Z; Xu C; Xu G; Sun Y
Mol Cell Proteomics; 2016 Jan; 15(1):154-63. PubMed ID: 26545398
[TBL] [Abstract][Full Text] [Related]
7. Model-driven discovery of long-chain fatty acid metabolic reprogramming in heterogeneous prostate cancer cells.
Marín de Mas I; Aguilar E; Zodda E; Balcells C; Marin S; Dallmann G; Thomson TM; Papp B; Cascante M
PLoS Comput Biol; 2018 Jan; 14(1):e1005914. PubMed ID: 29293497
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive reconstruction and in silico analysis of Aspergillus niger genome-scale metabolic network model that accounts for 1210 ORFs.
Lu H; Cao W; Ouyang L; Xia J; Huang M; Chu J; Zhuang Y; Zhang S; Noorman H
Biotechnol Bioeng; 2017 Mar; 114(3):685-695. PubMed ID: 27696371
[TBL] [Abstract][Full Text] [Related]
9. The adverse effects of aldrin and dieldrin on both myometrial contractions and the secretory functions of bovine ovaries and uterus in vitro.
Wrobel MH; Grzeszczyk M; Mlynarczuk J; Kotwica J
Toxicol Appl Pharmacol; 2015 May; 285(1):23-31. PubMed ID: 25771128
[TBL] [Abstract][Full Text] [Related]
10. Low Doses of PFOA Promote Prostate and Breast Cancer Cells Growth through Different Pathways.
Charazac A; Hinault C; Dolfi B; Hautier S; Decondé Le Butor C; Bost F; Chevalier N
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887249
[TBL] [Abstract][Full Text] [Related]
11. Integration of transcriptomic data in a genome-scale metabolic model to investigate the link between obesity and breast cancer.
Granata I; Troiano E; Sangiovanni M; Guarracino MR
BMC Bioinformatics; 2019 Apr; 20(Suppl 4):162. PubMed ID: 30999849
[TBL] [Abstract][Full Text] [Related]
12. Proteotranscriptomic Measurements of E6-Associated Protein (E6AP) Targets in DU145 Prostate Cancer Cells.
Gulati T; Huang C; Caramia F; Raghu D; Paul PJ; Goode RJA; Keam SP; Williams SG; Haupt S; Kleifeld O; Schittenhelm RB; Gamell C; Haupt Y
Mol Cell Proteomics; 2018 Jun; 17(6):1170-1183. PubMed ID: 29463595
[TBL] [Abstract][Full Text] [Related]
13. Metabolic deregulation in prostate cancer.
Srihari S; Kwong R; Tran K; Simpson R; Tattam P; Smith E
Mol Omics; 2018 Oct; 14(5):320-329. PubMed ID: 30215656
[TBL] [Abstract][Full Text] [Related]
14. Computational Approaches to Assess Abnormal Metabolism in Alzheimer's Disease Using Transcriptomics.
Lüleci HB; Uzuner D; Çakır T; Thambisetty M
Methods Mol Biol; 2023; 2561():173-189. PubMed ID: 36399270
[TBL] [Abstract][Full Text] [Related]
15. Plumbagin elicits differential proteomic responses mainly involving cell cycle, apoptosis, autophagy, and epithelial-to-mesenchymal transition pathways in human prostate cancer PC-3 and DU145 cells.
Qiu JX; Zhou ZW; He ZX; Zhao RJ; Zhang X; Yang L; Zhou SF; Mao ZF
Drug Des Devel Ther; 2015; 9():349-417. PubMed ID: 25609920
[TBL] [Abstract][Full Text] [Related]
16. Exploring candidate biomarkers for lung and prostate cancers using gene expression and flux variability analysis.
Asgari Y; Khosravi P; Zabihinpour Z; Habibi M
Integr Biol (Camb); 2018 Feb; 10(2):113-120. PubMed ID: 29349465
[TBL] [Abstract][Full Text] [Related]
17. Network-based analysis of prostate cancer cell lines reveals novel marker gene candidates associated with radioresistance and patient relapse.
Seifert M; Peitzsch C; Gorodetska I; Börner C; Klink B; Dubrovska A
PLoS Comput Biol; 2019 Nov; 15(11):e1007460. PubMed ID: 31682594
[TBL] [Abstract][Full Text] [Related]
18. [Advances in the development of constraint-based genome-scale metabolic network models].
Zhou J; Liu P; Xia J; Zhuang Y
Sheng Wu Gong Cheng Xue Bao; 2021 May; 37(5):1526-1540. PubMed ID: 34085441
[TBL] [Abstract][Full Text] [Related]
19. Toxicological profile of organochlorines aldrin and dieldrin: an Indian perspective.
Sharma N; Garg D; Deb R; Samtani R
Rev Environ Health; 2017 Dec; 32(4):361-372. PubMed ID: 28915126
[TBL] [Abstract][Full Text] [Related]
20. Discovery of therapeutic agents for prostate cancer using genome-scale metabolic modeling and drug repositioning.
Turanli B; Zhang C; Kim W; Benfeitas R; Uhlen M; Arga KY; Mardinoglu A
EBioMedicine; 2019 Apr; 42():386-396. PubMed ID: 30905848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
